Home » Topics » Disease categories and therapies » Cancer

Cancer
RSS

New phase II data on the efficacy of 3-AP plus gemcitabine in pancreatic cancer

Feb. 18, 2005

Janex-1 reduces tumorigenesis and improves survival in a mouse model of FAP

Feb. 18, 2005

Cytotoxic activity of HMN-176 in an array of human tumor specimens

Feb. 17, 2005

Six series of phosphatidylinositol 3-kinase inhibitors and their use reported by Pfizer

Feb. 17, 2005

Antitumor efficacy of temsirolimus in neuroendocrine carcinomas

Feb. 17, 2005

Update on the antitumor effects of NPI-0052 in colorectal cancer

Feb. 17, 2005

Good safety profile found for E-7070 plus irinotecan in cancer patients

Feb. 17, 2005

NV-1020 reported safe in patients with hepatic colorectal metastases

Feb. 17, 2005

Positive phase II interim results for talabostat in metastatic melanoma

Feb. 17, 2005

Vertex licenses VX-944 to Avalon for cancer

Feb. 17, 2005

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 13, 2026.
FENS 2026: Next-gen biologics take on brain disease
BioWorld
Whether by fine-tuning neurotransmitter signaling or silencing disease-associated genes, emerging biologic therapies are reshaping neuroscience drug development,...
Ionis, AZ shares down on unexpected Wainua flop in cardiomyopathy
BioWorld
News of the unexpected phase III failure of the gene silencing drug Wainua (eplontersen) in the treatment of transthyretin-mediated amyloid cardiomyopathy sent...
Neurovalens granted FDA approval for PTSD therapy for US veterans
BioWorld
Veterans in the U.S. suffering from post-traumatic stress disorder (PTSD) now have access to Neurovalens Ltd.’s Modius Spero, a wearable neuromodulation device,...
NRF2 activators reported in Vailima Peninsula patent
BioWorld Science
Vailima Peninsula Pty Ltd. has discovered new nuclear factor erythroid 2-related factor 2 (NFE2L2; NRF2) activators potentially useful for the treatment of...